(Q39833436)

15 September 2017

Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients (English)

1 reference

15 September 2017

1 reference

Jadeja L

1

1 reference

15 September 2017

Bolivar R

2

1 reference

15 September 2017

Fainstein V

3

1 reference

15 September 2017

Keating M

4

1 reference

15 September 2017

McCredie K

5

1 reference

15 September 2017

Hay M

6

1 reference

15 September 2017

Bodey GP

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1984

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

3

1 reference

15 September 2017

295-299

1 reference

Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

In vitro studies of piperacilin, a new semisynthetic penicillin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

In Vitro Activity of Furazlocillin (Bay k 4999) Compared with Those of Mezlocillin, Piperacillin, and Standard Beta-Lactam Antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Piperacillin: In Vitro Evaluation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Combination Therapy With Ticarcillin and Sulfamethoxazole-Trimethoprim for Infections in Patients With Cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Gram-negative bacillary pneumonia in the compromised host

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Carbenicillin Therapy for Pseudomonas Infections

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176155

Therapeutic trials with tobramycin

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6508260

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.26.3.295

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

6508260

1 reference